BELGRADE, Mont. , Aug. 10, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions

Raises 2023 Annual Revenue Guidance to $75 Million – $77 Million   BELGRADE, Mont. , Aug. 01, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc.

Acquisition to Enhance Xtant’s Growing Spinal Fusion Devices Portfolio BELGRADE, Mont. , July 28, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT),

BELGRADE, Mont. , July 25, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions

BELGRADE, Mont. , July 07, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions

BELGRADE, Mont. , July 03, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions

BELGRADE, Mont. , May 18, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions

Initiates Annual Revenue Guidance of $73 Million – $75 Million in Full Year 2023 BELGRADE, Mont. , May 04, 2023 (GLOBE NEWSWIRE) — Xtant Medical

BELGRADE, Mont. , April 27, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions

BELGRADE, Mont. , March 07, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions